Debra L. Morris - 13 May 2025 Form 4 Insider Report for biote Corp. (BTMD)

Role: Director
Signature: /s/ Marybeth Conlon, as Attorney-in-Fact for Debra L. Morris
Issuer symbol: BTMD
Transactions as of: 13 May 2025
Net transactions value: $0
Form type: 4
Filing time: 15 May 2025, 11:26:51 UTC
Previous filing: 21 Jan 2025
Next filing: 27 May 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
MORRIS DEBRA L	Director	C/O BIOTE CORP., 1875 W. WALNUT HILL LN #100, IRVING	/s/ Marybeth Conlon, as Attorney-in-Fact for Debra L. Morris	14 May 2025	0001838995

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BTMD	Class A Common Stock	Options Exercise		+11,045	+28%		50,155	13 May 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BTMD	Deferred Settlement RSU	Options Exercise	$0	-11,045	-100%	$0.000000	0	13 May 2025	Class A Common Stock	11,045		Direct	F1, F2
transaction	BTMD	Deferred Settlement RSU	Award	$0	+21,407		$0.000000	21,407	13 May 2025	Class A Common Stock	21,407		Direct	F1, F3
transaction	BTMD	Stock Option (Right to Buy)	Award	$0	+104,547		$0.000000	104,547	13 May 2025	Class A Common Stock	104,547	$3.91	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Deferred Settlement RSU is the economic equivalent of one share of Issuer Class A Common Stock.
F2	The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the earlier of calendar year 2025 or the date of the Reporting Person's separation from service.
F3	The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the earlier of calendar year 2026 or the date of the Reporting Person's separation from service.
F4	All shares subject to the option award shall vest on the earlier of May 13, 2026 or the day prior to the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.